Sharon Benzeno

Chief Commercial Officer, Immune Medicine at Adaptive Biotechnologies

Sharon Benzeno, PhD, has served as our Chief Business Development Officer since April 2020 and, before this, in business development roles of ascending responsibility with us since September 2014. Prior to joining us, Sharon served as Senior Director at Elsevier Inc., a healthcare informatics company, from December 2013 to September 2014, as Senior Manager in the oncology business unit at Capgemini SE, a French consulting and technology services company, from May 2011 to December 2013, and as Oncology Alliance Manager and Senior Scientific Manager at AstraZeneca plc from September 2005 to May 2011. Sharon holds a PhD in Biomedical Sciences from New York University School of Medicine, an MBA in Finance and Leadership from New York University Stern School of Business and a BA in Biochemistry from New York University. She completed a postdoctoral fellowship in cancer biology at the University of Pennsylvania Abramson Cancer Center.

Location

New York, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Adaptive Biotechnologies

17 followers

Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.


Employees

501-1,000

Links